The behavioral healthcare space is a growing industry and over the coming years, it is expected to grow at an impressive clip. Investors are now increasingly looking for companies that are involved in this sector and there are a lot of choices.
One of those is Ethema Health Corporation, which is focused primarily on treating people with substance abuse disorders. Over the course of the past decade, the company has been involved in honing a specific type of treatment and has managed to achieve considerable success with adult patients. The company has noted that it is committed to the development of world-class initiatives and technologies for the North American market.
As it happens, Ethema Health was in the news not too long ago back on November 29, 2022, when it announced its financial results for the third fiscal quarter of the year. It announced that its subsidiary unit named ARIA continued on its growth trajectory as it ended up with an EBITDA of $712,839 in the first nine months of the year.
On the other hand, its fully owned subsidiary unit PB Billing LLC clocked an EBITDA of $34,579 during the same period. However, in this context, it is important to keep in mind that Ethema Health completed the acquisition of PB Billing in May of 2022.
As a whole, the company managed to generate an EBITDA of $898,920 for the first nine months of the year. However, that is not all. It was also announced at the time that back on November 14, 2022, Ethema Health had managed to get the qualification for its Form 1A from the United States Securities and Exchange Commission. That was a major development since it would allow it to work towards raising fresh equity as it had indicated in the actual filing.
